Patho week 3 Flashcards
(65 cards)
Autoantibodies in SLE
Antinuclear antibodies (ANAs) → not specific
Anti-Smith and Anti-ds-DNA → specific
Epidemiology of SLE
Women → 20-40 years old
Hispanic and african american
HLA-DR2 and HLA-DR3
Hallmark of SLE
Production autoantibodies
Method for detecting ANAs
Immunofluorescence
Antibodies that can give a false-positive tests related to syphilis
Antibodies vs b-glycoprotein complex (also binds to cardiolipin)
Environmental factor that exacerbates SLE
Exposure UV light
Drugs that can contribute to SLE
Hydralazine, procainamide, D-penicillamine
Type of hypersensitivity in SLE
Type III: immune complex-mediated
Morphology of blood vessels in SLE
Vasculitis
Cutaneous characteristic of SLE
Butterfly rash → erythema affects face along bridge of nose and cheeks
Type of endocarditis found in SLE
Libman-Sacks endocarditis
Skin manifestations may mimic SLE but systemic manifestations are rare
Chronic discoid lupus erythomatosus
Features intermediate between SLE and chronic discoid lupus
Subacute cutaneous lupus erythematosus
Most common pattern of kidney disease in SLE
Class IV
Nephrotic (proteinuria) classes of kidney disease in SLE
Class I and V
Nephritic (hematuria) classes of kidney disease in SLE
Class II, III, IV
Class I of kidney disease in SLE
**Minimal mesangial lupus nephritis
Normal glomeruli but mesangial immune complex deposits
Class II of kidney disease in SLE
Mesangial proliferative lupus nephritis
Mesangial cell proliferation and granular mesangial deposits
Class III of kidney disease in SLE
Focal lupus nephritis
Involvement <50% glomeruli
Glomeruli exhibits swelling and proliferation of endothelial and mesangial cells
Class IV of kidney disease in SLE
Diffuse lupus nephritis
Half or more glomeruli affected)
Endothelial, mesangial and epithelial cells involved
Wire loops
Class V of kidney disease in SLE
Membranous lupus nephritis
Diffuse thickening of capillary walls due to deposition of subepithelial immune complexes
Subepithelial podocytes → non proliferative
Class VI of kidney disease in SLE
Advanced sclerosing lupus nephritis
Sclerosis >90% glomeruli, end stage renal disease
Epidemiology of rheumatoid arthritis
Women 20-40 years old
HLA-DR4 and HLA-DR1
Risk factors → infection & smoking
Pathogenesis of rheumatoid arthritis
Autoimmune response initiated by CD4 helper T cells
Autoantibodies specific for citrullinated peptides (CCPs) → arginine residues are converted to citrulline